ABERNETHY MATT bought NBIX
February 13, 2026 · Form 4 insider transaction
ABERNETHY MATT bought 44,095 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
44,095
Price
$0.00
Total value
N/A
InsiderABERNETHY MATT
RoleDirector
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2026
Filing dateFebruary 17, 2026
Shares owned after44,095
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.